Khalil Rountree can now breathe a sigh of relief, having recently received a reduced penalty for self-reporting his use of performance-enhancing drugs (PEDs).
“The War Horse” withdrew from his scheduled bout against Jamahal Hill in the co-main event of UFC 303 on June 29, after disclosing that he had tested positive for a banned substance known as Dehydroepiandrosterone (DHEA), a type of steroid hormone.
Rountree explained that he had been using a customized supplement and that the provider had mistakenly delivered a tainted product containing the prohibited substance.
However, according to a recent report by MMA journalist John Morgan, the Nevada Athletic Commission (NAC) announced on Thursday that Rountree’s ongoing sanction, which began on May 4, has been reduced to four and a half months.
Alongside the suspension, which wraps up on September 18, “The War Horse” has been ordered to pay prosecution fees amounting to $157. The NAC highlighted that Rountree’s proactive self-reporting played a crucial role in mitigating his penalty.
With the reduced suspension, Rountree is now cleared to participate in his eagerly awaited title bout against reigning light heavyweight champion Alex Pereira, slated to headline UFC 307 on October 5 at the Delta Center in Salt Lake City, Utah.
Rountree is coming off a third-round knockout victory over former title challenger Anthony Smith at a Fight Night event in December 2023. He is currently riding a five-fight win streak, including finishes over Chris Daukaus, Karl Roberson, and Modestas Bukauskas.
Continue Reading Khalil Rountree Receives Lighter Sentence After Self-Reporting PED Usage at MMA News.